Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study
Acta Obstetricia et Gynecologica Scandinavica · 2024
DOI: 10.1111/aogs.14987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Julia Lichtenstein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Sciences and Education, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Postpartum Hemorrhage, Fatty Acids, Omega-3, Registries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vetenskapsrådet.
Abstract (Originalsprache)
Introduction
Although Omega‐3 is thought to have anticoagulative properties, the potential untoward effects of Omega‐3 during pregnancy have not been investigated. No previous studies have been made to specifically assess its effect on postpartum hemorrhage (PPH). Our aim was to determine if an association exists between Omega‐3 intake during pregnancy and profuse PPH or massive PPH. Material and Methods Data on all deliveries that occurred at Karolinska University Hospital during the years 2007–2011 ( n = 41 139) was collected from the medical record of Obstetrix, maternal health and delivery chart system. Women with reported Omega‐3 use in early pregnancy were considered exposed and all other as unexposed. Bivariate and adjusted multivariate analysis was performed on main outcomes.
Results
Omega‐3 use was associated with 25% increased odds of PPH (adjusted odds ratio (aOR) 1.25, 95% confidence interval [CI] (1.06–1.47)) and a more than doubled odds of massive PPH (aOR 2.36, 95% CI 1.26–4.44). In addition, there was a minor increase in the amount of blood loss. Although few, women on low‐dose discontinued terminated at 36th week showed no significant association to blood loss measurements.
Conclusions
Our observational findings showed 25% higher odds of PPH and two times higher odds of massive PPH in women who reported using Omega‐3 in early pregnancy. Our findings give some support to advocate discontinued use of Omega‐3 in late pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Sciences and Education, Karolinska Institutet, Stockholm, Sweden.
- Division of Obstetrics and Gynecology, Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Hospital Huddinge, Stockholm, Sweden.
ORCID-Profile: Irene Sterpu, Pelle G Lindqvist
Förderung
- Vetenskapsrådet
Zitieren
APA
Lichtenstein, J., Sterpu, I., & Lindqvist, P. G. (2024). Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14987
Vancouver
Lichtenstein J, Sterpu I, Lindqvist PG. Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14987
BibTeX
@article{Lichtenstein2024,
author = {Lichtenstein, Julia and Sterpu, Irene and Lindqvist, Pelle G},
title = {Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2024},
doi = {10.1111/aogs.14987}
}
EUVIMED